APTA — Aptahem AB Share News
0.000.00%
Last trade - 00:00- SEK8.32m
- SEK6.60m
Brief: Aptahem AB Gets About Sek 25.4 Million Before Issue Costs In Rights Issue
Brief: Aptahem Q3 Pre-Tax Loss Widens To SEK 4.0 Million
Brief: Aptahem: New Sepsis Data Shows Good Effect In Apta-1 Treated Primates
Brief: Aptahem: Good Safety Profile For Apta-1
Brief: Aptahem Decides On Rights Issue Of About SEK 31.7 Million
Brief: Aptahem Q2 Pre-Tax Loss Widens To SEK 9.6 Million
Brief: Aptahem: Ongoing Pre-Clinical Toxicology Development Program Is Delayed
Brief: Aptahem: Yorkville Advisors Global Subscribe For 99,502 Shares In Co
Brief: Aptahem Enters Into Agreement With Yorkville Advisors Global
Brief: Aptahem And Seattle Children’S Research Institute Partner To Study Experimental Sepsis Drug
Brief: Aptahem Q1 Pretax Loss Widens To SEK 3.1 Million
Brief: Aptahem Q4 Pretax Loss At SEK 2.8 Million
Brief: Aptahem Starts Cooperation With Aptahem On Apta-1
Brief: Aptahem Q2 net loss at SEK 3.7 million
Brief: Aptahem enters production agreement with Biospring